CrunchBase is hiring! Check out our open positions →
Register | Login or Login

General Information

Websitevesaliusbiocapita...
Phone352-26-845682
Emailinfo@vesaliusbioc...
Employees
Founded2007

Funds

Offices

HQ
1B rue Thomas Edison
Strassen, L-1445, LUX

Tags

Vesalius Biocapital Partners

Vesalius Biocapital Partners manages a mid-size venture capital fund that invets in young, early and mid-stage European life science companies creating innovative drugs, diagnostics and cutting-edge biomedical technologies.

Recent Milestones

Investments

Company Date Round Size Participants
GenKyoTex 7/12Series C$26M4
Trinean 4/12Venture Round€2.7M3
Amakem 9/11Series A€18M4
GenKyoTex 5/11Series C$20.4M5
Activaero 2/11Series A€5M6
Complix 6/10Series A$6.2M3
Promethera Biosciences 2/10Series A$7.3M3
Activaero 11/09Series A$15.8M4
Trinean 10/08Venture Round$4.71M3

Videos

Sources

  1. Genkyotex Raises CHF25 Million in Series C Round Extension (finance.yahoo.com) [edit]
  2. Trinean appoints new CEO and secures 2.7 million euro financing. (trinean.com) [edit]
  3. Amakem Raises €18m in a Series a Round to Advance its Ophthalmology Drug Development Programs (prnewswire.com) [edit]
  4. GenKyoTex raises CHF 18 million in a Series C Venture Financing to develop NOX enzyme inhibitors (reuters.com) [edit]
  5. Activaero Raises EUR 5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP (cnbc.com) [edit]
  6. Complix, NV: Series A $6.2M (onbiovc.com) [edit]
  7. Promethera Biosciences, SA: Series A $7.3M (onbiovc.com) [edit]
  8. Activaero, GmbH: Series A $15.9M (businesswire.com) [edit]
  9. Citation Needed [add]
Edit This Page
Last Edited 4/25/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy